|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.12 USD | -0.12% |
|
-0.82% | +0.85% |
| 02-27 | Lumos Diagnostics Holdings Fiscal H1 Revenue Falls Slightly; Shares Up 3% | MT |
| 02-25 | ImpediMed Limited Appoints Erik Anderson as Independent Non-Executive Director, Effective 25 February 2026 | CI |
| Capitalization | 16.77B 14.66B 13.24B 12.67B 23.04B 1,551B 23.95B 158B 62.7B 741B 62.93B 61.6B 2,677B | P/E ratio 2026 * |
22.9x | P/E ratio 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise value | 16.51B 14.43B 13.04B 12.47B 22.68B 1,527B 23.58B 156B 61.71B 729B 61.94B 60.63B 2,635B | EV / Sales 2026 * |
3.9x | EV / Sales 2027 * | 3.49x |
| Free-Float |
74.01% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Hologic, Inc.
| 1 day | -0.12% | ||
| 1 week | -0.82% | ||
| Current month | -0.32% | ||
| 1 month | +0.11% | ||
| 3 months | +0.16% | ||
| 6 months | +16.56% | ||
| Current year | +0.85% |
| 1 week | 75.05 |  | 75.74 |
| 1 month | 74.95 | | 75.75 |
| Current year | 74.49 | | 75.75 |
| 1 year | 51.9 | | 75.75 |
| 3 years | 51.9 | | 87.88 |
| 5 years | 51.9 | | 87.88 |
| 10 years | 26.49 | | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 06/12/2013 | |
Karleen Oberton
DFI | Director of Finance/CFO | 56 | 31/07/2018 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 31/10/2011 | |
| Chairman | 62 | 15/06/2015 | |
| Director/Board Member | 71 | 14/05/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 2.06% | 4 M€ | |
| 0.00% | 1.98% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.12% | -0.82% | +23.74% | -5.34% | 16.77B | |
| -2.32% | -7.49% | -11.05% | -16.47% | 173B | |
| -1.48% | -3.67% | -2.53% | +100.68% | 168B | |
| +0.57% | -4.18% | -11.11% | -23.50% | 132B | |
| +0.85% | -3.11% | -28.85% | +43.10% | 103B | |
| -0.64% | -4.03% | -25.77% | -22.13% | 49.5B | |
| -3.31% | +0.21% | +18.07% | +4.62% | 47.52B | |
| -0.68% | -8.71% | +2.98% | +10.69% | 33.48B | |
| +0.63% | -4.71% | -13.66% | -8.26% | 32.25B | |
| -0.11% | -3.09% | -7.98% | -19.43% | 31.51B | |
| Average | -0.66% | -3.96% | -5.62% | +6.40% | 78.63B | |
| Weighted average by Cap. | -0.87% | -4.48% | -9.38% | +17.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.24B 3.7B 3.34B 3.2B 5.82B 392B 6.05B 39.96B 15.84B 187B 15.89B 15.56B 676B | 4.46B 3.9B 3.52B 3.37B 6.13B 412B 6.37B 42.07B 16.67B 197B 16.73B 16.38B 712B |
| Net income | 737M 644M 582M 556M 1.01B 68.12B 1.05B 6.95B 2.75B 32.55B 2.76B 2.71B 118B | 835M 730M 660M 631M 1.15B 77.26B 1.19B 7.88B 3.12B 36.91B 3.13B 3.07B 133B |
| Net Debt | -263M -230M -208M -199M -361M -24.31B -375M -2.48B -982M -11.61B -986M -965M -41.94B | -1.22B -1.07B -966M -925M -1.68B -113B -1.75B -11.55B -4.58B -54.08B -4.59B -4.5B -195B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 75.12 $ | -0.12% | 4,205,647 |
| 12/03/26 | 75.21 $ | -0.27% | 2,606,466 |
| 11/03/26 | 75.41 $ | -0.17% | 1,859,191 |
| 10/03/26 | 75.54 $ | -0.07% | 3,066,471 |
| 09/03/26 | 75.59 $ | -0.20% | 2,338,386 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition